Public trial registry of the CCC-Munich

Trial AIO-HEP-0117 IMMUCHEC

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO-HEP-0117 IMMUCHEC
World
Full title
:

A randomized phase II trial of durvalumab and tremelimumab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with cholangio- and gallbladder carcinoma

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Gallbladder carcinoma
- Gallbladder carcinoma
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Hana Algül 2. Med 2. Med Ismaninger Str. 22 81675 München Germany Magnifier